Director, Endocrinology

Dr. Henriksen joined Nordic Bioscience in 2002, and assumed the position as Director of Endocrinology in 2018. His research is focused on identification and development of novel peptide therapies for metabolic conditions, such as obesity, NASH and type 2 diabetes, and has resulted in patenting and development of two peptide families, namely the KBPs and the OXMs, which are moving rapidly towards clinical development.

H-Factor: 52, i10 index: 129, Citations 9837

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information to provide the best possible experience. By using our website, you agree to our Privacy Policy and our cookies usage. Cookie Policy Privacy Statement